Glucose/insulin/potassium therapy: a reevaluation of myocardial benefits during cardiopulmonary bypass.
Wiese
S
S
Askanazi
J
J
D000818:Animals; D002315:Cardiopulmonary Bypass; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D006003:Glycogen / Q000032:analysis; D006321:Heart / Q000187:drug effects*; D006324:Heart Arrest, Induced; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D007552:Isotonic Solutions / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D009206:Myocardium / Q000737:chemistry / Q000378:metabolism; D011188:Potassium / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D011292:Premedication
D007328:Insulin; D007552:Isotonic Solutions; C028570:Ringer's acetate; D006003:Glycogen; D005947:Glucose; D011188:Potassium